Search results
Found 31107 matches for
NDORMS team joins the race to develop a prototype for rapidly deployable ventilator
31 March 2020
An interdisciplinary team of engineers and medics is addressing ways to increase the UK's capacity for ventilator manufacture.
NDORMS researchers leading a virtual study-a-thon to tackle COVID-19
24 March 2020
The Observational Health Data Sciences and Informatics (OHDSI) international community will host a COVID-19 virtual study-a-thon this week (March 26-29) to inform healthcare decision-making in response to the current global pandemic.
Coronavirus information - what we are doing at NDORMS to support our staff and students and the community
20 March 2020
NDORMS announces the closure of the Kennedy and Botnar Institutes and outlines other plans and activities for the department during the pandemic.
The rationale and ethics of placebo controls in surgical trials
20 March 2020
A new Review, published in the Lancet, analyses the use of placebo controls in surgery and offers a practical checklist for researchers designing trials.
Researchers identify markers in joint fluid that could be the key to cartilage repair
9 March 2020
Molecular changes in the joint fluid during surgical joint distraction reveal markers that may drive cartilage repair in osteoarthritis.
CRUK success for NDORMS researchers
21 February 2020
Investigators based at the Kennedy Institute of Rheumatology, NDORMS have recently received CRUK awards to increase understanding of a variety of cancers and immunotherapy.
Skin cancer diagnosis apps are unreliable and poorly regulated, study shows
18 February 2020
Smartphone apps used as 'early warning systems' for skin cancer are poorly regulated and frequently cannot be relied upon to produce accurate results, according to new analysis by Abhilash Jain at NDORMS.
Sponsored place available for the Randomised Controlled Trials Course
13 February 2020
The inaugural Doug Altman scholarship will be offered to an LMIC (lower-to-middle-income country) applicant or a student.
Two prestigious Hunterian Professorships awarded to NDORMS researchers
12 February 2020
Professor Matthew Costa and Dr David Metcalfe have both been awarded Hunterian Professorships for 2020 by the Royal College of Surgeons of England
Incisional negative pressure wound therapy found to be no more effective than standard dressings
11 February 2020
A new method of treating wounds after major trauma costing nearly £150 per dressing is no more effective in reducing surgical infection rates than a standard wound dressing priced under £2, potentially saving the NHS millions.
Work starts on the PRO CURE study!
7 February 2020
An update on the PRO CURE study, which is currently in the process of setting up.
Researchers recommend early walking in a brace for Achilles tendon rupture
7 February 2020
A new study from NDORMS reveals a breakthrough for sportsmen and women in the treatment of Achilles tendon rupture.
FRUITI study now in set-up!
31 January 2020
An update on the FRUITI study, which is currently in the process of setting up.
Research Review of SARAH from Pedro
31 January 2020
In a new podcast Sallie Lamb, Head of the Rehabilitation Research Group at NDORMS talks about SARAH, the Strengthening and Stretching for Rheumatoid Arthritis of the Hand Trial.
Multidisciplinary project will explore AI in healthcare
31 January 2020
Professor Kassim Javaid has joined an interdisciplinary team embarking on a new 3-year project to advise on the best practice of Artificial Intelligence (AI) in healthcare to ensure it benefits everyone in the UK and Japan.
Two new Associate Professors at NDORMS
31 January 2020
Dr Fiona Watt and Professor Stephanie Dakin announced as Associate Professors
Work starts on PASHION study!
29 January 2020
An update on the PASHION study, which is currently in the process of setting up.
New collaboration will help researchers understand why cancer survival between patients differs
27 January 2020
NDORMS researchers join five other universities to investigate how cancer survivors make antibodies that target and destroy tumours, and explore routes for new treatments